Related Experiment Videos

Implications of albuminuria on kidney disease progression

George L Bakris1

  • 1Rush University Hypertension Center, Rush University Medical Center, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA. george_bakris@rush.edu

Journal of Clinical Hypertension (Greenwich, Conn.)
|November 13, 2004
PubMed

Insights

Albuminuria indicates cardiovascular and kidney disease risk. Reducing albuminuria with specific antihypertensive agents, particularly those blocking the renin-angiotensin-aldosterone system, improves outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Albuminuria is a key indicator of cardiovascular risk and kidney disease.
  • Microalbuminuria is linked to inflammation (elevated C-reactive protein), suggesting increased vascular permeability.
  • Progression to macroalbuminuria signifies worsening vascular and kidney disease.

Purpose of the Study:

  • To emphasize the importance of albuminuria reduction in managing hypertension and kidney disease.
  • To guide the selection of antihypertensive agents that effectively lower both blood pressure and albuminuria.

Main Methods:

  • Review of hypertension guidelines and recent outcome trials.
  • Analysis of the role of inflammation in microalbuminuria development.
  • Evaluation of antihypertensive strategies for albuminuria management.

Main Results:

  • Albuminuria reduction, alongside blood pressure control, is crucial for favorable outcomes in kidney disease progression.
  • Agents blocking the renin-angiotensin-aldosterone system are recommended for BP goals and albuminuria reduction.
  • Combination therapy (e.g., ACE inhibitors with ARBs) can significantly further reduce albuminuria.

Conclusions:

  • Antihypertensive therapy should prioritize agents that lower both blood pressure and albuminuria.
  • Targeting the renin-angiotensin-aldosterone system is a cornerstone of managing albuminuria.
  • Additional albuminuria reduction strategies, like dual RAAS blockade or adding specific agents, offer significant benefits beyond BP lowering.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...